Lam TK, Schwartz GJ, Rossetti L
Vaser is the treatment of choice for this type of fat
Abstract In healthy individuals, the incretin hormone glucagon-like peptide 1 (GLP1) potentiates insulin release and suppresses glucagon secretion in response to the ingestion of nutrients
Our data demonstrate that acetaminophen accumulates in Drosophila , resulting in the generation of ROS in the fat body (an organ analogous to the mammalian liver 21 ), a rapid depletion of systemic glutathione, and subsequent mortality
Treatment with a GLP-1R agonist resulted in a greater weight loss than control treatment did
The bottom line: GLP-1s have many health benefits, and while there is some evidence to support an association between them and serious eye conditions, that link should not be overstated, and must be considered within the greater context of your individual health